Recruiting trial = ; Ongoing trial = ; Funded by an IRDiRC member = ; Member of a ERN =

National clinical trial(s)

ITALY

EMILIA ROMAGNA
ADDRESS: NOT PROVIDED - IT

Follow-up of phase I/II study of CaspaCide T cells from an HLA-partially matched family donor after negative selection of TCR alfa-beta+ T cells in pediatric patients affected by hematological disorders

Institution: Information not provided - IT

More details

UNITED KINGDOM

Greater London
LONDON

CaspaCide TCR α β haplo HSCT: Follow-up of Phase 1/2 Study of CaspaCIDe T Cells (BPX-501) From an HLA-partially Matched Family Donor After Negative Selection of TCR α β+T Cells in Pediatric Patients Affected by Hematological Disorders-GB

GOSH NHS Foundatin Trust

Great Ormond Street Hospital

More details

Multinational clinical trial(s)

UNITED STATES

Texas
HOUSTON

CaspaCide TCR α β haplo HSCT: Follow-up of Phase 1/2 Study of CaspaCIDe T Cells (BPX-501) From an HLA-partially Matched Family Donor After Negative Selection of TCR α β+T Cells in Pediatric Patients Affected by Hematological Disorders

Bellicum Pharmaceuticals, Inc.

More details